Semaglutide (GLP-1)
$26.99
Semaglutide is a long-acting peptide studied for its activity as a glucagon-like peptide-1 (GLP-1) receptor agonist. It has been evaluated in extensive clinical research related to metabolic regulation, appetite signaling pathways, and glucose control mechanisms.
Usage Disclaimer: Research Use Only. This product is intended strictly for laboratory research and in-vitro studies. It is not for human or animal consumption, medical use, or diagnostic purposes. Any unauthorized use of this product is strictly prohibited.
FDA Compliance: FDA Notice. The statements made regarding these products have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
Research Studies
SELECT Cardiovascular Outcomes (2023)
17,604 participants | 2.4mg weekly | 5 years | 20% CV risk reduction
Major cardiovascular outcomes trial demonstrating 20% reduction in major adverse cardiovascular events in overweight/obese adults with established CVD.
STEP 5 Two-Year Maintenance (2022)
304 participants | 2.4mg weekly | 104 weeks | Sustained weight loss
Two-year study confirming sustained weight loss (15.2% at week 104) with continued treatment, demonstrating long-term efficacy.
STEP TEENS Adolescent Study (2022)
201 adolescents | 2.4mg weekly | 68 weeks | 16.1% BMI reduction
First trial in adolescents (12-17 years) with obesity showing significant BMI reduction and metabolic improvements.
Pair your peptide order with bacteriostatic water for proper reconstitution and storage. Adding it now ensures you have everything you need when your order arrives.
Avoid delays and complete your setup in one shipment.
